“Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFkB activation and apoptosis in an AAA+domain-dependent manner”

Takeda M, Tezuka T*, Kim M, Choi J, Oichi Y, Kobayashi H, Harada K, Mizushima T, Taketani S, Koizumi A, Youssefian S

Biochem Biophys Res Commun. 2020 Mar 2. pii: S0006-291X(20)30290-4.
https://www.ncbi.nlm.nih.gov/pubmed/32139119

(peer-reviewed)